Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Change in Inventory: 2019-2024

Historic Change in Inventory for Sunshine Biopharma (SBFM) over the last 6 years, with Dec 2024 value amounting to $6.0 million.

  • Sunshine Biopharma's Change in Inventory rose 2.66% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year decrease of 21.16%. This contributed to the annual value of $6.0 million for FY2024, which is 153.93% up from last year.
  • Latest data reveals that Sunshine Biopharma reported Change in Inventory of $6.0 million as of FY2024, which was up 153.93% from $2.4 million recorded in FY2023.
  • Sunshine Biopharma's Change in Inventory's 5-year high stood at $6.0 million during FY2024, with a 5-year trough of -$42,983 in FY2022.
  • Its 3-year average for Change in Inventory is $2.8 million, with a median of $2.4 million in 2023.
  • As far as peak fluctuations go, Sunshine Biopharma's Change in Inventory tumbled by 152.50% in 2022, and later spiked by 5,603.45% in 2023.
  • Yearly analysis of 5 years shows Sunshine Biopharma's Change in Inventory stood at $7,861 in 2020, then soared by 941.59% to $81,879 in 2021, then tumbled by 152.50% to -$42,983 in 2022, then skyrocketed by 5,603.45% to $2.4 million in 2023, then surged by 153.93% to $6.0 million in 2024.